Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 08 - 09 source : Www.biospace.com save search
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
VIR | $8.11 2.01% 1.97% 1.1M
|
Health Technology
|
| O: -1.76%
H: 2.0%
C: -2.34%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: -0.17%
H: 0.5%
C: -3.03%
update results
Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Progress in STS101 Development Program
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
STSA | $1.1 -0.9% -0.91% 0
|
Health Technology
| Email alert
Add to watchlist
sts101 program results
eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
EFTR | $1.7 -8.21% 180K
|
|
| O: 4.55%
H: 112.09%
C: -30.51%
therapeutics update results
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
XENE | $40.0 0.3% 0.3% 390K
|
Health Technology
|
| O: -0.13%
H: 1.24%
C: -0.63%
PCRX | $26.12 -0.5% -0.5% 380K
|
Health Technology
|
| O: 0.22%
H: 0.29%
C: -0.55%
update results
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
ABUS | $2.645 -2.76% -2.84% 740K
|
Health Technology
|
| O: -0.4%
H: 0.6%
C: -1.2%
results
INOVIO Reports Financial Results and Highlights for the Second Quarter 2022
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
INO | $10.005 3.36% 3.25% 330K
|
Health Technology
|
| O: -5.08%
H: 0.45%
C: -6.25%
Biote Reports Second Quarter 2022 Financial Results
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
HYAC 4 | $10.46 0.1% 0.0% 9.2K
|
Finance
| Email alert
Add to watchlist
results
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
LUMO | $2.64 1.93% 1.89% 4.7K
|
Health Technology
|
| O: 3.63%
H: 3.84%
C: -8.58%
pharma results
ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
CLPT | $5.49 3.0% 2.91% 49K
|
Health Technology
|
| O: 0.94%
H: 4.11%
C: -3.78%
fda clearance train
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
CELU | News F | $3.03 -3.88% 26K
|
|
| O: -0.97%
H: 4.23%
C: 1.95%
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.03%
H: 0.76%
C: 0.68%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: -0.03%
H: 1.02%
C: 0.47%
update results
NuVasive Announces Departure of Chief Commercial Officer
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
NUVA | $39.75 -2.24% -2.29% 0
|
Health Technology
|
| O: -0.6%
H: 0.83%
C: -0.48%
commercial
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 0.0%
H: 2.43%
C: -8.56%
update results
Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer
Published: 2022-08-09 (Crawled : 22:00) - biospace.com/
OLMA | $9.87 -0.6% -0.61% 680K
|
Health Technology
|
| O: -2.09%
H: 5.51%
C: -0.36%
op-1250 expansion cancer her2- phase 2 her2
PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights
Published: 2022-08-09 (Crawled : 19:00) - biospace.com/
PMVP | $1.725 7.14% 6.67% 540K
|
Commercial Services
|
| O: -1.46%
H: 1.42%
C: -6.7%
results
Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission
Published: 2022-08-09 (Crawled : 19:00) - biospace.com/
MOVE | $0.461 -6.38% -6.81% 70K
|
Manufacturing
|
| O: -2.16%
H: 11.39%
C: 5.15%
fda heart submission
ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-08-09 (Crawled : 17:00) - biospace.com/
ADCT | $4.69 -0.64% 0.0% 170K
|
Health Technology
|
| O: -2.24%
H: 2.67%
C: 1.27%
therapeutics results
J&J's Mathai Mammen Abruptly Departs in Latest Leadership Jolt
Published: 2022-08-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
Vivos Therapeutics Schedules Second Quarter 2022 Financial Results Conference CallCall Scheduled for Monday, August 15, 2022 at 5:00 pm ET
Published: 2022-08-09 (Crawled : 16:00) - biospace.com/
VVOS | $2.69 -1.1% -1.12% 31K
|
Health Technology
|
| O: -2.31%
H: 1.57%
C: -4.72%
conference therapeutics
Aytu BioPharma Announces Pricing of Public Offering
Published: 2022-08-09 (Crawled : 15:20) - biospace.com/
AYTU | $2.78 -0.36% -0.36% 6.6K
|
Health Technology
|
| O: -46.24%
H: 4.47%
C: -10.1%
offering biopharma
Prelude Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-09 (Crawled : 15:20) - biospace.com/
PRLD | $3.9 4.84% 4.62% 50K
|
Health Technology
|
| O: -1.53%
H: 1.86%
C: 0.93%
therapeutics update results
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.